High variability in Factor IX one‐stage assay in samples spiked with nonacog beta pegol among different pairs of reagent/detection system
International Journal of Laboratory Hematology · 2024
DOI: 10.1111/ijlh.14171 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Laboratory Hematology, 2024. Verfasst von C Duboscq und 6 weiteren Autor:innen. Beteiligte Einrichtung: Servicio Hematología, Hospital Británico, Buenos Aires, Argentina. Hauptthemen laut MEDLINE: Factor IX, Hemophilia B, Polyethylene Glycols. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: Instrumentation Laboratory, Novo Nordisk Argentina, Wiener SA.
Abstract (Originalsprache)
Introduction
Haemophilia B (HB) is an X‐linked hereditary bleeding disorder characterized by coagulation factor IX (FIX) deficiency. To improve the quality of life of patients and adherence to treatment, recombinant factor concentrates modified to extend their half‐life have been developed, called extended half‐life factors (EHL: extended half‐life). Nonacog beta pegol (N9‐GP) is a glycopegylated recombinant human FIX molecule that has a half‐life of 93 h with a single dose and has shown a higher recovery percentage than other molecules. To diagnose and monitor the treatment of haemophiliac patients, FIX activity is determined with the one‐stage clotting assay (OSA) and/or the chromogenic assay. The objective of this work, carried out in three centres, was to measure the recovery of N9‐PG with 10 different activated partial thromboplastin time (APTT) reagents on three platforms, in samples spiked in vitro with N9‐GP, at four different concentration levels.
Methods
It was measured the recovery of N9‐GP with 10 different APTT reagents (polyphenol, ellagic acid, silice dioxide, colloidal silica as APTT activator on three platforms, in sample spiked in vitro with N9‐GP.
Results
The results show heterogeneity in the activity of N9‐GP measured by OSA with the different APTT reagents when the calibrations were performed with the specific calibrator of each coagulometer. A recovery percentage between 87% and 108% was obtained only with polyphenol and ellagic acid as activator in the three platforms evaluated. The other reagents studied overestimate or underestimate, with no clear profile. When a calibration curve was performed with a calibrator prepared from the N9‐GP vial, all APTT reagents met the established recovery requirement.
Conclusion
APTT reagents with polyphenol or ellagic acid as activator would be the only ones appropriate when using the commercially available OSA with specific calibrator to monitor patients treated with N9‐GP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Servicio Hematología, Hospital Británico, Buenos Aires, Argentina.
- Laboratorio de Hematología Y Hemostasia, Hospital Dr. César Milstein, Buenos Aires, Argentina.
- Laboratorio Central Hospital, Hospital Universitario Austral, Buenos Aires, Argentina.
- Servicio de Hemofilia, Dr. César Milstein, Buenos Aires, Argentina.
Förderung
- Instrumentation Laboratory
- Novo Nordisk Argentina
- Wiener SA
Zitieren
APA
Duboscq, C., Sueldo, E., Rosa, C., Zirpoli, M., Ceresetto, J., Baques, A., & Arias, M. (2024). High variability in Factor IX one‐stage assay in samples spiked with nonacog beta pegol among different pairs of reagent/detection system. International Journal of Laboratory Hematology. https://doi.org/10.1111/ijlh.14171
Vancouver
Duboscq C, Sueldo E, Rosa C, Zirpoli M, Ceresetto J, Baques A, et al. High variability in Factor IX one‐stage assay in samples spiked with nonacog beta pegol among different pairs of reagent/detection system. International Journal of Laboratory Hematology. 2024. doi:10.1111/ijlh.14171
BibTeX
@article{Duboscq2024,
author = {Duboscq, C and Sueldo, E and Rosa, C and Zirpoli, M and Ceresetto, J and Baques, A and Arias, M},
title = {High variability in Factor IX one‐stage assay in samples spiked with nonacog beta pegol among different pairs of reagent/detection system},
journal = {International Journal of Laboratory Hematology},
year = {2024},
doi = {10.1111/ijlh.14171}
}
EUVIMED